Ophthalmology Perspectives | Ep 1 | Patient Recruitment in Ophthalmology Trials

In this conversation today, we're going to dive into the evolving landscape of patient recruitment in ophthalmology and explore how Belite Bio and Fortrea are collaborating to overcome protocol complexities, and discuss the unique opportunities Asia PAC represents for ocular development. We'll also look ahead to the most promising trends shaping the future of ophthalmology trials. Host: Amber BurgParticipants: Tanya Richardson Fortrea’s Therapeutic Strategy Head for Neuroscience and OphthalmologyLisa Liang, Senior Director of Clinical Operations at Belite Bio.